ERSTE Stock Biotec D02 VTIA/  AT0000A1YFG4  /

Fonds
NAV08/11/2024 Chg.+20.0999 Type of yield Investment Focus Investment company
3,311.9299CZK +0.61% Full reinvestment Equity Sector Biotechnology Erste AM 
 

Investment goal

The ESPA STOCK BIOTEC fund invests in the most important biotech companies, primarily those in the USA. Equities from the Pacific region and Europe play a minor role, but are also selectively added to the fund. The currencies are not hedged against the euro. The fund is particularly suitable as an addition to an existing equity portfolio and is geared towards achieving long-term capital appreciation.
 

Master data

Type of yield: Full reinvestment
Funds Category: Equity
Country: United States of America
Branch: Sector Biotechnology
Benchmark: Solactive United States Biotechnology Index NTR
Business year start: 15/03
Last Distribution: -
Depository bank: Erste Group Bank AG
Fund domicile: Austria
Distribution permission: Austria, Germany, Czech Republic
Fund manager: Harald Kober, Tamas Menyhart
Fund volume: 235.91 mill.  EUR
Launch date: 22/12/2017
Investment focus: -

Conditions

Issue surcharge: 4.00%
Max. Administration Fee: 0.63%
Minimum investment: 0.00 CZK
Deposit fees: -
Redemption charge: 0.00%
Key Investor Information: Download (Print version)
 

Investment company

Funds company: Erste AM
Address: Am Belvedere 1, 1100, Wien
Country: Austria
Internet: www.erste-am.at
 

Assets

Stocks
 
99.55%
Cash
 
0.45%

Countries

United States of America
 
78.89%
United Kingdom
 
9.10%
Netherlands
 
3.92%
China
 
1.96%
Denmark
 
1.19%
Virgin Islands (British)
 
1.06%
Bermuda
 
1.00%
Canada
 
0.85%
Ireland
 
0.69%
Cash
 
0.45%
Singapore
 
0.34%
Cayman Islands
 
0.30%
Belgium
 
0.17%
Spain
 
0.08%

Branches

Pharma/Biotechnology
 
96.10%
Healthcare services
 
3.44%
Cash
 
0.45%
Others
 
0.01%